Literature DB >> 33552462

The Value of Sacral Reflex and Sympathetic Skin Reflex in the Diagnosis of Multiple System Atrophy P-Type.

Xiaohang Li1, Chengju Wang2, Xueming Zhang3, Wanli Zhang2, Binbin Deng2, Xun Wang2, Huanjie Huang2.   

Abstract

OBJECTIVES: To observe the characteristics of sacral reflex and sympathetic skin reflex in patients with Parkinson's disease (PD) and multiple system atrophy P-type (MSA-P) and to analyze their value as a differential diagnostic method.
METHODS: The data of 30 healthy people, 58 PD patients, and 52 MSA-P patients from the First Affiliated Hospital of Wenzhou Medical University were collected. Electrophysiological bulbocavernosus reflex (BCR) and sympathetic skin response (SSR) were evaluated using the Keypoint EMG/EP system. The latency period, amplitude, and extraction rate of BCR and SSR were compared between the control, PD, and MSA-P groups.
RESULTS: The incidence of the related autonomic damage in the PD group was lower than that of the MSA-P group. For BCR, the latency period was shorter and the amplitude and elicitation rates were lower in the PD group than in the MSA-P group. For SSR, the latency period was longer in the MSA-P and PD groups than in the control group, but the difference was not statistically significant.
CONCLUSION: SSR cannot be used to assess autonomic nerve function. PD patients can have clinical symptoms similar to those of MSA-P patients, but the incidence is lower. Both MSA-P and PD patients have a damage to the BCR arc, but the MSA-P patients have a more severe damage.
Copyright © 2021 Xiaohang Li et al.

Entities:  

Year:  2021        PMID: 33552462      PMCID: PMC7843193          DOI: 10.1155/2021/6646259

Source DB:  PubMed          Journal:  Parkinsons Dis        ISSN: 2042-0080


  27 in total

1.  Aging effects of sympathetic reflex activities on skin nerves.

Authors:  Harue Watanabe; Kazumasa Shindo; Haruyasu Ida; Haruyuki Tanaka; Takamura Nagasaka; Zenji Shiozawa
Journal:  Gerontology       Date:  2003 Nov-Dec       Impact factor: 5.140

2.  Neuropathological features of multiple system atrophy with cognitive impairment.

Authors:  Y T Asi; Helen Ling; Z Ahmed; A J Lees; T Revesz; J L Holton
Journal:  Mov Disord       Date:  2014-04-18       Impact factor: 10.338

3.  A case of multiple system atrophy with normal dopamine transporter imaging.

Authors:  Matej Kolenc; Mara Popović; Marko Grmek; Zvezdan Pirtošek; Maja Trošt
Journal:  J Neurol       Date:  2012-09-07       Impact factor: 4.849

4.  Mutant COQ2 in multiple-system atrophy.

Authors:  Manu Sharma; Gregor Wenning; Rejko Krüger
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

5.  Normal dopamine transporter imaging does not exclude multiple system atrophy.

Authors:  John McKinley; Martin O'Connell; Michael Farrell; Timothy Lynch
Journal:  Parkinsonism Relat Disord       Date:  2014-05-04       Impact factor: 4.891

6.  The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?

Authors:  Jie-Ying Feng; Biao Huang; Wan-Qun Yang; Yu-Hu Zhang; Li-Min Wang; Li-Juan Wang; Xiao-Ling Zhong
Journal:  Acta Radiol       Date:  2014-03-11       Impact factor: 1.990

7.  Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.

Authors:  David R Williams; Andrew J Lees
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

8.  Genetic background of apparently idiopathic sporadic cerebellar ataxia.

Authors:  L Schöls; S Szymanski; S Peters; H Przuntek; J T Epplen; C Hardt; O Riess
Journal:  Hum Genet       Date:  2000-08       Impact factor: 4.132

9.  CAG repeat expansions in patients with sporadic cerebellar ataxia.

Authors:  N Futamura; R Matsumura; Y Fujimoto; H Horikawa; A Suzumura; T Takayanagi
Journal:  Acta Neurol Scand       Date:  1998-07       Impact factor: 3.209

10.  Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study.

Authors:  José Berciano; Francesc Valldeoriola; Isidre Ferrer; Jordi Rumià; Julio Pascual; Concepción Marín; María J Rey; Eduardo Tolosa
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.